 Home > Biochemistry News > Biotechnology News > Bifunctional antibodies for the treatment of autoimmune diseases show a new mode of suppressing immune response

Bifunctional antibodies for the treatment of autoimmune diseases show a new mode of suppressing immune response

 Last Update: 2021-12-01
 Source: Internet
 Author: User

Tags

represent

nerve cell image

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A few days ago, Xencor announced that Zenas BioPharma has obtained the global development, production and commercialization rights of the research antibody obexelimab from Xencor

In autoimmune diseases, activated B cells are one of the main factors that attack one's own cells and tissues

Early clinical studies have shown that obexelimab can effectively inhibit B cell function without depleting cells, and has produced encouraging therapeutic effects in patients with a variety of autoimmune diseases

Reference materials:

[1] Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor.

[2] Interim Results of a Phase 2 Study of XmAb®5871, a Reversible B Cell Inhibitor, in IgG4-Related Disease.

(The original text has been deleted)

*Disclaimer: This article is written by the author of Sina Medical News.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Express treatment of autoimmune diseases, bifunctional antibodies show a new mode of suppressing immune response

12-05

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

Bifunctional antibodies for the treatment of autoimmune diseases show a new mode of suppressing immune response

Related Articles

Express treatment of autoimmune diseases, bifunctional antibodies show a new mode of suppressing immune response